(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.

CAS No.: 1569807-15-3

Chemical Name:: (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.

Synonyms: 1',2'-f][1,3,2]dioxaphosphepin,99%e.e.;3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1';R-3,3'-Bis[1,1':3',1''-terphenyl]-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate;(11bR)-2,6-di([1,1':3',1''-terphenyl]-5'-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin;Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-, 4-oxide, (11bR)-;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1'':3'',1''''-terphenyl]-5''-yl)-4-oxide-dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin;(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.

CBNumber:: CB43152096

Molecular Formula:: C56H45O4P

Molecular Weight:: 812.93

MOL File:: 1569807-15-3.mol

Modify Date:: 2022/8/26 12:10:07

Request For Quotation

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e. Properties

Density	1.34±0.1 g/cm3(Predicted)
pka	1.14±0.20(Predicted)

SAFETY

Risk and Safety Statements

Symbol(GHS)	GHS07
Signal word	Warning
Hazard statements	H315
Precautionary statements	P264-P280-P302+P352-P332+P313-P362+P364

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e. Preparation Products And Raw materials

Raw materials

Preparation Products

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e. Suppliers

Global( 24)Suppliers

Supplier	Tel	Country	ProdList	Advantage	Inquiry
Shanghai Daken Advanced Materials Co.,Ltd	+86-371-+86-371-66670886	China	19841	58	Inquiry
Aladdin Scientific		United States	57505	58	Inquiry
Shanghai Aladdin Biochemical Technology Co.,Ltd.	400-6206333 13167063860	China	48458	58	Inquiry
Shanghai Anyinuo Biomedical Technology Co., Ltd.	021-34625901	China	5843	58	Inquiry
Bide Pharmatech Ltd.	400-164-7117 13681763483	China	41457	60	Inquiry
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd	025-58851090 17714375163	China	13012	58	Inquiry
Nantong Hanfang Biotechnology Co. , Ltd.	hanfangpharma@126.com; 18616537568	China	29981	58	Inquiry
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	China	6576	65	Inquiry
Shanghai Haohong Pharmaceutical Co., Ltd.	400-8210725 4008210725	China	40026	58	Inquiry
Shanghai YuanYe Biotechnology Co., Ltd.	021-61312847; 18021002903	China	71829	60	Inquiry

Supplier	Advantage
Shanghai Daken Advanced Materials Co.,Ltd	58
Aladdin Scientific	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	58
Shanghai Anyinuo Biomedical Technology Co., Ltd.	58
Bide Pharmatech Ltd.	60
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd	58
Nantong Hanfang Biotechnology Co. , Ltd.	58
Daicel Chiral Technologies (China)CO.,LTD	65
Shanghai Haohong Pharmaceutical Co., Ltd.	58
Shanghai YuanYe Biotechnology Co., Ltd.	60

1569807-15-3((11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.)Related Search:

R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-diphenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate (S)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate (S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin S- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(1-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

(R)-4-oxide-2,6-bis[4-(4-methoxyphenyl)--8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (R)-3,3'-Bis(2,4,6-trimethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthyl Hydrogen Phosphate (11bR)-2,6-bis[3,5-bis(1,1-diMethylethyl)-4-Methoxyphenyl]-4-hydroxy-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[4-(trifluoromethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin R-3,3'-bis(4-nitrophenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate

(R)-4-oxide-2,6-bis[4-(1,1-dimethylethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (S)-4-oxide-2,6-bisbis([1,1':3',1''-terphenyl]-5'-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

chevron_left

1of4

chevron_right

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e. (11bR)-2,6-di([1,1':3',1''-terphenyl]-5'-yl)-4-hydroxy-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-, 4-oxide, (11bR)- R-3,3'-Bis[1,1':3',1''-terphenyl]-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate 3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d 1',2'-f][1,3,2]dioxaphosphepin,99%e.e. (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1' (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98% (99% ee) (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1'':3'',1''''-terphenyl]-5''-yl)-4-oxide-dinaphtho[2,1-d:1'',2''-f][1,3,2]dioxaphosphepin (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 1569807-15-3 C56H45O4P